These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6369974)

  • 21. The importance of in-vitro susceptibility testing in the management of compromised hosts.
    Venditti M; Martino P
    J Chemother; 1997 May; 9 Suppl 1():116-22. PubMed ID: 9248970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients].
    Groll AH; Ritter J
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S37-66. PubMed ID: 16288352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Empiric treatment of fungal infections in the neutropenic host. Review of the literature and guidelines for use.
    Sugar AM
    Arch Intern Med; 1990 Nov; 150(11):2258-64. PubMed ID: 2241435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unusual pulmonary infections in immunodeficiency.
    Valdés-Dapena MA
    Ann Clin Lab Sci; 1973; 3(3):224-33. PubMed ID: 4540864
    [No Abstract]   [Full Text] [Related]  

  • 26. Current needs in chemotherapy for bacterial and fungal infections.
    Young LS
    Rev Infect Dis; 1985; 7 Suppl 3():S380-8. PubMed ID: 3901205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis, prevention and treatment of infections of bacterial, fungal and viral origin in immunocompromised patients].
    Kurrle E; Schmeiser T
    Onkologie; 1984 Feb; 7 Suppl 1():37-45. PubMed ID: 6371640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of pneumonia in childhood].
    Dietzsch HJ
    Z Arztl Fortbild (Jena); 1989; 83(6):301-4. PubMed ID: 2660432
    [No Abstract]   [Full Text] [Related]  

  • 32. Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients.
    Straus SE; Smith HA; Brickman C; de Miranda P; McLaren C; Keeney RE
    Ann Intern Med; 1982 Mar; 96(3):270-7. PubMed ID: 7059087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment with acyclovir of an immunodeficient patient infected simultaneously with multiple herpesviruses.
    Cupps TR; Straus SE; Waldmann TA
    Am J Med; 1981 Apr; 70(4):882-6. PubMed ID: 6259942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Indications for antimicrobial treatment in immunocompromised granulocytopenic patients].
    Ternák G; Almási I
    Orv Hetil; 1995 Aug; 136(32):1707-12. PubMed ID: 7651704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current world literature. Antimicrobial agents: bacterial/fungal.
    Curr Opin Infect Dis; 2003 Dec; 16(6):613-28. PubMed ID: 15043065
    [No Abstract]   [Full Text] [Related]  

  • 36. Infections in immunocompromised patients. I. Pathogenesis, etiology, and diagnosis.
    Klastersky J
    Clin Ther; 1985; 8(1):90-9. PubMed ID: 3914372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of infectious complications of acquired immunodeficiency syndrome.
    Furio MM; Wordell CJ
    Clin Pharm; 1985; 4(5):539-54. PubMed ID: 2996829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.
    Am J Med; 1989 Jun; 86(6 Pt 1):668-72. PubMed ID: 2658574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV: prevention of opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2005 Jun; (13):834-53. PubMed ID: 16135281
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fungal infections in the granulocytopenic patient].
    Martino P; Micozzi A; Girmenia C; Raccah R; Gentile G
    Haematologica; 1989 Oct; 74(5 Suppl):320-31. PubMed ID: 2512217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.